Inventor · disambiguated record
Narges K. Tafreshi
Also filed as: TAFRESHI NARGES · TAFRESHI NARGES K
7 granted patents·5 pending applications·2 citations·filing 2011–2024
75Inventor score
Top patents by PatentIndex Score
12 records- 0187US2025129118A1Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 0278US12173087B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Dec 24, 2024·0 cites·18 claims
- 0377US12508329B2Radiotherapeutic and companion imaging agents to target MC1RH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Dec 30, 2025·0 cites·19 claims
- 0474US11230568B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Jan 25, 2022·0 cites·18 claims
- 0573US9441013B2Melanocortin 1 receptor ligands and methods of useGILLIES ROBERT J·Filed 2012·Granted Sep 13, 2016·2 cites·16 claims
- 0670US11406723B2Radiotherapeutic and companion imaging agents to target MC1RH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Aug 9, 2022·0 cites·12 claims
- 0759US10329326B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Jun 25, 2019·0 cites·8 claims
- 0856US2024269281A1Car-t cell therapy for triple negative breast cancerH LEE MOFFITT CANCER CT & RES·Filed 2022·Application pending·0 cites
- 0955US2018126013A1Radiotherapeutic and companion imaging agents to target mc1rH LEE MOFFITT CANCER CT & RES·Filed 2016·Application pending·0 cites
- 1052US2023115540A1Tumor targeted fluorescence guidance for intraoperative margin assessmentH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 1141US2023382819A1Processes for synthesis of alpha-emitting radiopharmaceuticalsH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 1239US11077212B2Molecular imaging of cancer cells in vivoMORSE DAVID L·Filed 2011·Granted Aug 3, 2021·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →